Abstract
Inadequate research on female health and performance; the complexity of the research; low menstrual health literacy of athletes, coaches, and support staff; and ethical and cultural sensitivities are all recognized as barriers to effective health monitoring for females in sports. Frameworks have been developed for academics to follow to help improve the quality of female-specific research. However, a similar resource that enables correct terminology, and use of health monitoring techniques has not been provided for sporting organizations, coaches, support staff or athletes. Therefore, this critical commentary presents a new resource, the Menstrual Health Manager. This resource may be used to determine the level of menstrual health monitoring detail that may be used by organisations, coaches or athletes, and specifies what reproductive health details the data will provide. This resource aims to provide organizations and coaches with a means of understanding the data that inform their decisions for female athletes. Utilization of this resource may aid in the consistent use of terminology and methods for female-specific health monitoring in both sports and research.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Inadequate research, low menstrual health literacy, and lack of educational resources and training are barriers that prevent effective menstrual health monitoring for females, for both active individuals and elite athletes. |
The development of educational resources that use correct terminology (in lay language) is required for athletes, coaches and support staff. This strategy could help improve appropriate and effective menstrual cycle health monitoring for females in sport and exercise environments. |
A decision tree has been constructed for coaches, sporting organizations and athletes to inform decision-making on what menstrual health monitoring methods could be used, while also ensuring that there is some understanding/learning of what information will be provided. |
1 Introduction
In 2023, the FIFA Women’s World Cup broke attendance records, drawing the largest crowds and ticket sales for a female-specific sporting event [1]. The year preceding this record-breaking World Cup event, the Tokyo Olympic Games demonstrated near parity in participation by male and female athletes, with Britain, Canada, China and Australia sending teams that were female-dominant [2]. However, the substantial growth in female sport participation has yet to be met with equality or equity in media coverage, salaries, athlete support (e.g., maternity leave, childcare support, mental and physical health), female leadership, female coaches, female-specific data and evidence-informed recommendations. As a result, in more recent times, an increase in sporting organization scrutiny by both athletes and media [3,4,5] has been observed. Organizations are criticized for their lack of female welfare and support, and subsequently calls to action have moved for improvements in policies and education from grassroots through to elite female athletes [5]. However, when turning to the research sector to inform education, performance and training recommendations, these organizations and individuals will find limited evidence [6].
To consolidate the available research on “How does the menstrual cycle affect exercise, sports performance, health, and well-being”, numerous audits of the available literature have been completed. These audits have investigated the extent of cis-female representation in the participant pool in sport medicine and exercise science journals [7], nutrition studies [8], research methodology [9, 10], menstrual cycle symptoms [11] and sport/exercise performance [12, 13]. Subsequently, these audits demonstrate how the issues of small sample sizes, the low quality in study design, and heterogeneity between studies and individuals have cumulatively contributed to a substantial cis-female data gap in sport and exercise science. As such, most sporting organizations have access to countless reviews that state that there is limited research evidence to inform adjustment of training, recovery or nutrition to the physiology of individuals who menstruate [8, 12, 13].
The data gap in cis-female research are also contributing to the consistent reports of low menstrual health literacy within sports [14]. Inadequate menstrual health literacy or menstrual health education will adversely influence the validity of the data provided by the individual on their menstrual health [15]. In addition, the reliability of menstrual health data may be questioned, especially when coaches and sporting organizations are faced with data-reporting compliance issues. For example, following the initial implementation of menstrual health data tracking, there may be high compliance by athletes due to its novelty. However, without coaches and support staff providing clear objectives on why data are being collected, there is a risk that once there is an increase in self-awareness or survey fatigue the consistency and reliability of data reporting may be reduced [15]. Of note, in the absence of athletes understanding why menstrual health data are being collected, the reporting of this health data may raise ethical concerns for athletes about how the data will be used by coaches and the organization [16]. Subsequently, counterarguments to the praise of menstrual health data collection and awareness within sports include misinterpretation of data, incorrect decisions on training, and performance, potential loss of privacy of the athlete, and disrespect for cultural sensitivities on the topic [16].
There is no argument that the menstrual cycle is a marker of female health. However, in the absence of high-quality research data, effective use of in-field data is likely to only occur once key issues pertaining to menstrual health literacy for athletes, coaches and support staff are addressed. Inadequate menstrual cycle and/or hormonal contraception knowledge of coaches has been suggested as a primary barrier to athlete communication, regardless of whether athletes rate their athlete-coach relationship favourably. Discussions with female coaches may occur more readily, but may still be limited to the coach’s education or influenced by the coach’s personal experiences/biases with their cycle. Exacerbated by the lack of formal education/discussions on the menstrual cycle and inadequacy of available research, any application of menstrual cycle tracking, monitoring or adjustment of training may be perceived as difficult, especially in the context of elite sports [17]. Therefore, education and resources that enable athletes, coaches and support staff to understand what they can monitor with regard to the menstrual cycle are required. This initial process may be beneficial to sporting organizations that wish to implement menstrual health discussions and health data collection in a culturally and ethically appropriate manner.
2 Basis for Resource Development
In the interim, standardizing menstrual health terminology and methodology by organizations, coaches and athletes should be considered a priority. Previously, academic experts in the field of sport and exercise have provided guidelines and a framework for current and future academics to consider when designing cis-female-specific in-lab research projects [10]. The provision of this framework has sought to remove the barriers that will enable high-quality research projects that are then able to provide evidence-based guidelines for female exercisers, their coaches, and support staff. Specifically, this work provided definitions of the female reproductive system and the diversity that may need to be considered throughout the lifespan both within and between cis-females. However, it is recognized that this paper was designed to improve research quality, and as such meets the needs of its primary target audience, academics and researchers in medicine, exercise and sport science. Therefore, the usability of this paper for applied, in-field support and education is limited.
Previous research acknowledges that even if menstrual health information is acquired by coaches, the complexity of the information remains a barrier to its usability (e.g., communication, understanding and awareness) [17]. Training management and physical performance are key considerations for coaches who desire a greater understanding of the physiological nuances that occur when working with female athletes [18]. To date, there is insufficient evidence available to suggest individualized training based on menstrual cycle phases or characteristics [13]. There may, however, be a consideration for individualized recovery and support provided to female exercisers/athletes that considers their unique physiology [18]. However, this may only be achieved with both coaches and athletes being aware and having transparent agreements on (1) what health data are being provided, (2) how these data may affect the discussions and management of the menstrual cycle, and (3) what data should be considered, collected and reported to ensure the individual’s privacy is maintained. As such, the following resource has been developed for cis-female athletes/exercisers, coaches and support staff to inform their decisions on menstrual health monitoring. The resource should enable any implemented health monitoring processes to remain in alignment with guidelines provided by academic experts in female-specific exercise and sport science.
3 Menstrual Health Manager (MHM)
To enable simple and informed decision-making on what menstrual health monitoring methods could be used, while also ensuring that there is some understanding/learning of what information will be provided, decision trees for menstrual cycle status have been developed (Figs. 1, 2, 3). Decision trees have been used in medical and healthcare settings to provide a support system that enables reliable and effective decisions to be made by practitioners [19, 20]. Decision trees provide a means of classification based on a series of questions on the features or characteristics associated with data [20]. The tree commences at the root node, and in this instance, the root node of ‘female’. The decision tree provides a series of questions, and each of these questions is contained within a node. In a simple binary format, each question of the decision tree has a simple yes or no response, with each possible answer directing the user to a specified child node [20].
Within this paper and the decision trees, the term ‘female’ was used to describe individuals designated with the biological sex characteristics that would enable menstruation to occur [21]. Historically, ‘female’ and ‘women’ post-puberty have both been used in the research literature to describe individuals who menstruate. However, it is acknowledged that the term ‘women’ may be used to describe the individual’s gender, with gender recognized as a social construct that depicts the roles and behaviors of individuals [21]. The decision tree has been designed for cis-gender females based on the presence of ovarian steroid concentrations. However, both sex and gender are not binary, and this may need to be considered when using this resource.
There are two outcomes when using the decision tree as a means of understanding what methods can be used to monitor menstrual health that athletes, coaches or support staff may consider. Firstly, users may select to work from the root node through a series of questions to a node that has no further questions, i.e. a leaf. To ensure adequate understanding and learning when using the resource, an expanded definition of each leaf of Figs. 1 and 2 is provided in Table 1, while a lay summary and image of the hormonal profile (endogenous estrogen and progesterone levels) associated with each leaf are provided in Fig. 3. For each leaf, a code has been provided to allow the user to find the appropriate menstrual cycle profile (Fig. 3) or description (Table 1). Users may then select to implement the in-depth menstrual health monitoring protocol that enables them to reach the relevant leaves. Details on what menstrual health monitoring tools or methods may be used to help respond to each of the binary questions within Fig. 2 are provided in Table 2. In Fig. 2, to ensure alignment with the recent IOC-REDs Clinical Assessment Tool [22], the suggestion of medical support to review the menstrual health status or required medical review of the identified menstrual health status has been provided.
Secondly, sporting organizations may use the decision trees to inform health monitoring processes. Thus, identify the amount of personal health data they may consider collecting, ensuring ethical and cultural sensitivities are respected. Specifically, it is acknowledged that there are ethnic and cultural differences in knowledge, practices and traditions concerning the menstrual cycle. The use of methodologies (e.g., blood sample collection, cervical mucus) that do not consider these diverse values of athletes could increase the risk of discrimination of individuals in an organization and result in inaccurate data due to the lack of engagement in implemented health monitoring [23]. In these instances, to ensure cultural safety is maintained, the users may work through the decision tree from the root node, selecting to stop at a more conservative node and not progress with any further questions to a leaf. Again, Table 2 may be used to help inform which menstrual health monitoring practices coaches and sporting organizations may use to inform health-specific decision-making with female athletes. For both circumstances, the author has provided the frequency with which menstrual health monitoring tools may be used to help inform decision-making and support provided to female athletes. These recommendations are based on the work previously completed by academic experts who have experience in female athlete health monitoring [24].
In recognition that not all premenopausal females may be naturally menstruating, a decision tree for hormonal contraception, a common hormonal milieu of active females [25,26,27], has been provided (Fig. 4). Hormonal contraception is defined as the provision of exogenous reproductive hormones that suppress endogenous reproductive hormone levels and may inhibit ovulation for the duration of time that the hormonal contraception is used [12]. The exception is the hormonal intrauterine device (IUD), where localized secretions of progestins have been shown to not inhibit ovulation throughout the duration of use [28].
Insights from research have suggested that the most utilized form of hormonal contraception is the combined oral contraceptive pill [25, 27, 29,30,31]; note, however, that there are many alternatives that females may have been prescribed [32,33,34], or have selected based on individual preferences. Due to different types, and brands, as well as the duration of exogenous hormone dose [12, 35], variations in exogenous hormone concentrations may occur. Therefore, while the choice of hormonal contraception remains that of the individual, support staff or coaches may use the flow chart to understand the various types that females may use and the methods by which they use these exogenous hormones (e.g., schedule). The flow chart is not provided as a tool to adjust or advise on hormonal contraception use: rather it is provided as an educational resource to inform athletes, support staff and coaches of the different types of hormonal contraception that an individual may use. This resource may be used to understand how hormonal contraception forms differ from each other and to naturally menstruating females. Additional details of each type of hormonal contraception are provided in Table 3. Finally, what health monitoring approaches may or may not be used for females who choose to use hormonal contraceptives have been provided in Table 2.
The decision tree has primarily been made for cis-females who are classified as premenopausal, and future versions of the resource may incorporate decision trees for females at different life-cycle stages. However, in recognition of the various life-cycle stages that females may experience, Table 4 has highlighted some critical changes in female reproduction, detailing the basic physiological changes and subsequent presentations and considerations for health monitoring.
In recognition of common menstrual cycle disorders that females, both athletes and active individuals, may present with, Table 5 again defines the disorder and considerations for health, well-being and exercise/training monitoring. These definitions and considerations have been based on previous research on each of the conditions [36,37,38,39,40,41,42]. Details on health monitoring have been provided to support organizations or staff working with athletes at these various life-cycle stages or with a menstrual cycle disorder, providing a conservative framework to consider when implementing female health monitoring in sport and exercise. The resources are not diagnostic tools. Rather, if support staff or coaches identify common symptoms of disorders as a result of the menstrual health monitoring process, then it is advised that they seek out medical support and consultation.
4 Conclusion
The decision trees and tables in this paper have been developed to educate and assist athletes, sports organizations and coaches with a framework that will enable them to develop or review their menstrual health monitoring methods. They are not suggested or intended as resources that can be used as diagnostic tools. It is anticipated these resources will help determine the details of menstrual health monitoring that may be implemented, while also ensuring that an improved understanding of the menstrual cycle occurs while still acknowledging the ethical and cultural perspectives of the individual/s providing the data. As such, these resources are likely to provide options for improved female health and well-being support and communication within a sporting environment that have previously been identified as barriers for coaches and support staff.
Inclusion of data availability
As this is a short review and commentary all data is in the figures and tables which are presented as part of the article. There is no additional data that requires an availability statement.
References
FIFA Women’s World Cup 2023TM breaks new records [Internet]. InsideFIFA. 2023. https://www.fifa.com/tournaments/womens/womensworldcup/australia-new-zealand2023/media-releases/fifa-womens-world-cup-2023-tm-breaks-new-records. Cited 31 Jul 2023.
Pegoraro A, Arndt F. The Tokyo Olympics are billed as the first gender equal Games, but women still lack opportunities in sport. The Conversation [Internet]. 2021: https://theconversation.com/the-tokyo-olympics-are-billed-as-the-first-gender-equal-games-but-women-still-lack-opportunities-in-sport-165280. Cited 31 Jul 2023.
Thorpe H. Turning despair into action for female athletes | Newsroom [Internet]. Lockeroom. 2022 https://www.newsroom.co.nz/lockerroom/turning-despair-into-action-for-female-athletes. Cited 07 Aug 2023.
Maheshwari S. Why elite female athletes are turning away from major sponsors—The New York Times [Internet]. The New York Times. 2021: https://www.nytimes.com/2021/07/30/business/female-athletes-sponsorship-apparel.html. Cited 07 Aug 2023.
Alvarez A. I thought the main issue in women’s sports was equal pay. I was wrong | Sport | The Guardian [Internet]. The Guardian. 2019 https://www.theguardian.com/sport/2019/may/09/i-thought-the-main-issue-in-womens-sports-was-equal-pay-i-was-wrong. Cited 07 Aug 2023.
Cowley ES, Olenick AA, McNulty KL, Ross EZ. “Invisible sportswomen”: the sex data gap in sport and exercise science research. Women Sport Phys Act J. 2021;29:146–51.
Costello JT, Bieuzen F, Bleakley CM. Where are all the female participants in sports and exercise medicine research? Eur J Sport Sci. 2014;14:847–51. https://doi.org/10.1080/17461391.2014.911354.
Kuikman MA, Smith ES, McKay AKA, Ackerman KE, Harris R, Elliott-Sale KJ, et al. Fueling the female athlete: auditing her representation in studies of acute carbohydrate intake for exercise. Med Sci Sports Exerc. 2023;55:569.
Smith ES, McKay AKA, Ackerman KE, Harris R, Elliott-Sale KJ, Stellingwerff T, et al. Methodology review: a protocol to audit the representation of female athletes in sports science and sports medicine research. Int J Sport Nutr Exerc Metab. 2022;1:1–14.
Elliott-Sale KJ, Minahan CL, de Jonge XAKJ, Ackerman KE, Sipilä S, Constantini NW, et al. Methodological considerations for studies in sport and exercise science with women as participants: a working guide for standards of practice for research on women. Sports Med. 2021;51:843–61. https://doi.org/10.1007/s40279-021-01435-8.
Taim BC, Catháin CÓ, Renard M, Kirsty, Elliott-Sale J, Madigan S, et al. The prevalence of menstrual cycle disorders and menstrual cycle-related symptoms in female athletes: a systematic literature review. Sports Med. 2023. https://doi.org/10.1007/s40279-023-01871-8.
Elliott-Sale KJ, McNulty KL, Ansdell P, Goodall S, Hicks KM, Thomas K, et al. The effects of oral contraceptives on exercise performance in women: a systematic review and meta-analysis. Sports Med. 2020. https://doi.org/10.1007/s40279-020-01317-5.
McNulty KL, Elliott-Sale KJ, Dolan E, Swinton PA, Ansdell P, Goodall S, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Med. 2020. https://doi.org/10.1007/s40279-020-01319-3.
McGawley K, Sargent D, Noordhof D, Badenhorst CE, Julian R, Govus AD. Improving menstrual health literacy in sport. J Sci Med Sport. 2023. https://doi.org/10.1016/j.jsams.2023.06.007.
Adnan T, Coull BA, Jukic AM, Mahalingaiah S. The real-world applications of the symptom tracking functionality available to menstrual health tracking apps. Curr Opin Endocrinol Diabetes Obes. 2021;28:574–86.
Casto KV. Tracking women’s reproductive data in sport: practical limitations, perils and pitfalls. Sports Med. 2022;52:1723–7.
Höök M, Bergström M, Sæther SA, McGawley K. “Do elite sport first, get your period back later” are barriers to communication hindering female athletes? Int J Environ Res Public Health. 2021;18:12075.
Clarke A, Govus A, Donaldson A. What male coaches want to know about the menstrual cycle in women’s team sports: performance, health, and communication. Int J Sports Sci Coach. 2021;16:544–53. https://doi.org/10.1177/1747954121989237.
Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision trees: an overview and their use in medicine. J Med Syst. 2002;26:445–63. https://doi.org/10.1023/A:1016409317640.
Kingsford C, Salzberg SL. What are decision trees? Nat Biotechnol. 2008;26:1011–3.
Pandit A, Tran TB, Letton M, Cowley E, Gibbs M, Wewege MA, et al. Data informing governing body resistance-training guidelines exhibit sex bias: an audit-based review. Sports Med. 2023. https://doi.org/10.1007/s40279-023-01878-1.
Stellingwerff T, Mountjoy M, McCluskey WT, Ackerman KE, Verhagen E, Heikura IA. Review of the scientific rationale, development and validation of the International Olympic Committee Relative Energy Deficiency in Sport Clinical Assessment Tool: V2 (IOC REDs CAT2)—by a subgroup of the IOC consensus on REDs. Br J Sports Med. 2023;57:1109–18.
Gibbons AE, Pedlar C, Hemi KV, Bruinvels G, Hamilton B, Thorpe H. Moving from ethnic exclusions to cultural safety: how is athlete ethnicity discussed in research on menstrual health in sports? A scoping review. Br J Sports Med 2024 https://bjsm.bmj.com/content/early/2024/02/26/bjsports-2023-107449. Cited 29 Feb 2024.
Bruinvels G, Pedlar C. Tracking health and fitness variables in females: Menstrual cycle considerations. In: Hackney AC, editor. Sex hormones, exercise & women. 2nd ed. Cham: Springer Nature; 2022.
Clarke AC, Bruinvels G, Julian R, Inge P, Pedlar CR, Govus AD. Hormonal contraceptive use in football codes in Australia. Front Sports Act Living. 2021. https://doi.org/10.3389/fspor.2021.634866.
Schaumberg MA, Emmerton LM, Jenkins DG, Burton NW, Janse-de-Jonge XAK, Skinner TL. Use of oral contraceptives to manipulate menstruation in young, physically active women. Int J Sports Physiol Perform. 2018;13:82–7.
Martin D, Sale C, Cooper SB, Elliott-Sale KJ. Period prevalence and perceived side effects of hormonal contraceptive use and the menstrual cycle in elite athletes. Int J Sports Physiol Perform. 2018;13:926–32.
Nilsson CG, Lähteenmäki P, Luukkainen T. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD. Contraception. 1980;21:225–33.
Heather A, Thorpe H, Ogilvie M, Sims S, Beable S, Milsom S, et al. Biological and socio-cultural factors have the potential to influence the health and performance of elite female athletes: a cross sectional survey of 219 elite female athletes in aotearoa New Zealand. Front Sports Act Living. 2021. https://doi.org/10.3389/fspor.2021.601420.
Brown N, Roldan-Reoyo O, Williams GKR, Stodter A, Moore IS, Mackintosh KA, et al. Profiling hormonal contraceptive use and perceived impact on training and performance in a global sample of women rugby players. Int J Sports Physiol Perform. 2023;18:1–7.
Cheng J, Santiago KA, Abutalib Z, Temme KE, Hulme A, Goolsby MA, et al. Menstrual irregularity, hormonal contraceptive use, and bone stress injuries in collegiate female athletes in the United States. PM&R. 2021;13:1207–15.
Spritzer PM. Contraception in the context of PCOS. Med Sci (Paris). 2022;38:177–81.
Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opin Pharmacother. 2018;19:1109–25.
Brown J, Farquhar C. Endometriosis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.CD009590.pub2.
Elliott-Sale KJ, Smith S, Bacon J, Clayton D, McPhilimey M, Goutianos G, et al. Examining the role of oral contraceptive users as an experimental and/or control group in athletic performance studies. Contraception. 2013;88:408–12.
Bruinvels G, Burden R, Brown N, Richards T, Pedlar C. The prevalence and impact of heavy menstrual bleeding (Menorrhagia) in elite and non-elite athletes. PLoS ONE. 2016;11: e0149881.
Ellis K, Munro D, Clarke J. Endometriosis is undervalued: a call to action. Front Glob Womens Health. 2022. https://doi.org/10.3389/fgwh.2022.902371.
Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand. 2014;93:52–7. https://doi.org/10.1111/aogs.12292.
Vannuccini S, Fondelli F, Clemenza S, Galanti G, Petraglia F. Dysmenorrhea and heavy menstrual bleeding in elite female athletes: quality of life and perceived stress. Reprod Sci. 2020;27:888–94.
Lin AW, Kazemi M, Jarrett BY, vanden Brink H, Hoeger KM, Spandorfer SD, et al. Dietary and physical activity behaviors in women with polycystic ovary syndrome per the new international evidence-based guideline. Nutrients. 2019;11:2711.
Bonocher CM, Montenegro ML, Rosa-e-Silva JC, Ferriani RA, Meola J. Endometriosis and physical exercises: a systematic review. Reprod Biol Endocrinol. 2014;12:1–5. https://doi.org/10.1186/1477-7827-12-4.
Kiel IDAA, Lionett S, Parr EB, Jones H, Roset MAH, Salvesen O, et al. High-intensity interval training in polycystic ovary syndrome: a two-center, three-armed randomized controlled trial. Med Sci Sports Exerc. 2022;54:717–27.
de Jonge XJ, Thompson B, Ahreum HAN. Methodological recommendations for menstrual cycle research in sports and exercise. Med Sci Sports Exerc. 2019;51:2610–7.
Brown JB, Thomas A. Types of ovarian activity in women and their significance: the continuum (a reinterpretation of early findings). Hum Reprod Update. 2011;17:141–58.
McNulty KL, Ansdell P, Goodall S, Thomas K, Elliott-Sale KJ, Howatson G, et al. The symptoms experienced by naturally menstruating women and oral contraceptive pill users and their perceived effects on exercise performance and recovery time posttraining. Women Sport Phys Act J. 2023;1:1–13.
Bruinvels G, Goldsmith E, Blagrove R, Simpkin A, Lewis N, Morton K, et al. Prevalence and frequency of menstrual cycle symptoms are associated with availability to train and compete: a study of 6812 exercising women recruited using the Strava exercise app. Br J Sports Med. 2021;55:438–43.
Miller PB, Soules MR. The usefulness of a urinary LH kit for ovulation prediction during menstrual cycles of normal women. Obstetr Gynecol. 1996;87:13–7.
Bedford JL, Prior JC, Hitchcock CL, Barr SI. Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability. Eur J Obstet Gynecol Reprod Biol. 2009;146:76–80.
Prior JC, Vigna YM, Schulzer M, Hall JE, Bonen A. Determination of luteal phase length by quantitative basal temperature methods: validation against the midcycle LH peak. Clin Investig Med. 1990;13:123–31.
Su H, Yi Y, Wei T, Chang T, Cheng C. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017;2:238.
Steward K, Raja A. Physiology, ovulation and basal body temperature. StatPearls. 2023. https://www.ncbi.nlm.nih.gov/books/NBK546686/. Cited 12 Mar 2024.
Lei TH, Cotter JD, Schlader ZJ, Stannard SR, Perry BG, Barnes MJ, et al. On exercise thermoregulation in females: interaction of endogenous and exogenous ovarian hormones. J Physiol. 2019;597:71–88.
Han L, Taub R, Jensen JT. Cervical mucus and contraception: what we know and what we don’t. Contraception. 2017;96:310–21.
Stanford JB, Schliep KC, Chang CP, O’Sullivan JP, Porucznik CA. Comparison of woman-picked, expert-picked, and computer-picked Peak Day of cervical mucus with blinded urine luteinising hormone surge for concurrent identification of ovulation. Paediatr Perinat Epidemiol. 2020;34:105–13.
Hirschberg AL. Challenging aspects of research on the influence of the menstrual cycle and oral contraceptives on physical performance. Sports Med. 2022;52:1453–6.
Lakehomer H, Kaplan PF, Wozniak DG, Minson CT. Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students. Contraception. 2013;88:426–30.
Panicker S, Mann S, Shawe J, Stephenson J. Evolution of extended use of the combined oral contraceptive pill. J Fam Plann Reprod Health Care. 2014;40:133–41.
Findlay RJ, MacRae EHR, Whyte IY, Easton C, Forrest LJ. How the menstrual cycle and menstruation affect sporting performance: experiences and perceptions of elite female rugby players. Br J Sports Med. 2020;54:1108–13.
Wright KP, Johnson JV. Evaluation of extended and continuous use oral contraceptives. Ther Clin Risk Manag. 2008;4:905.
Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception. 2006;74:439–45.
Burrows M, Peters CE. The influence of oral contraceptives on athletic performance in female athletes. Sports Med. 2007. https://doi.org/10.2165/00007256-200737070-00001.
Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181:1263–9.
Xiao B, Zeng T, Wu S, Sun H, Xiao N. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use. Contraception. 1995;51:359–65.
Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007;75:S16-30.
Lumbers ER, Pringle KG. Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol. 2014;306:91–101. https://doi.org/10.1152/ajpregu.00034.2013.
Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165:1667–72.
Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96:1533–40. https://doi.org/10.1210/jc.2010-2395.
Risberg A, Olsson K, Lyrenäs S, Sjöquist M. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand. 2009;88:639–46.
Goldsmith LT, Weiss G. Relaxin in human pregnancy. Ann N Y Acad Sci. 2009;1160:130–5. https://doi.org/10.1111/j.1749-6632.2008.03800.x.
O’Leary P, Boyne P, Flett P, Beilby J, James I. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem. 1991;37:667–72. https://doi.org/10.1093/clinchem/37.5.667.
Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014. https://doi.org/10.3389/fphar.2014.00065.
Hartgill TW, Bergersen TK, Pirhonen J. Core body temperature and the thermoneutral zone: a longitudinal study of normal human pregnancy. Acta Physiol. 2011;201:467–74. https://doi.org/10.1111/j.1748-1716.2010.02228.x.
Dehghan F, Haerian BS, Muniandy S, Yusof A, Dragoo JL, Salleh N. The effect of relaxin on the musculoskeletal system. Scand J Med Sci Sports. 2014;24: e220.
Alex A, Bhandary E, McGuire KP. Anatomy and physiology of the breast during pregnancy and lactation. Adv Exp Med Biol. 2020;1252:3–7. https://doi.org/10.1007/978-3-030-41596-9_1.
McGhee DE, Steele JR. Biomechanics of breast support for active women. Exerc Sport Sci Rev. 2020;48:99–109.
Johnson MS, Jackson DL, Schust DJ. Endocrinology of pregnancy. In: Encyclopedia of reproduction. Elsevier; 2021. p. 469–76.
Onaade O, Maples JM, Rand B, Fortner KB, Zite NB, Ehrlich SF. Physical activity for blood glucose control in gestational diabetes mellitus: rationale and recommendations for translational behavioral interventions. Clin Diabetes Endocrinol. 2021;7:1–9. https://doi.org/10.1186/s40842-021-00120-z.
Uvnas-Moberg K, Ekstrom-Bergstrom A, Buckley S, Massarotti C, Pajalic Z, Luegmair K, et al. Maternal plasma levels of oxytocin during breastfeeding—a systematic review. PLoS ONE. 2020;15: e0235806. https://doi.org/10.1371/journal.pone.0235806.
Lewis PR, Brown JB, Renfree MB, Short RV. The resumption of ovulation and menstruation in a well-nourished population of women breastfeeding for an extended period of time. Fertil Steril. 1991;55:529–36.
Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstetr Gynecol. 2011;117:657–62.
Reproductive K, Porpora G, Wieczorek K, Targonskaya A, Maslowski K. Reproductive hormones and female mental wellbeing. Women. 2023;3:432–44.
Schulz JM, Marmura H, Hewitt CM, Parkinson LJ, Thornton JS. Navigating the ‘new normal’: what guidelines exist for postpartum return to physical activity and sport? A scoping review. Br J Sports Med. 2023;57:1573–8.
Albracht-Schulte KD, García-González Á, Wilson S, Robert-McComb JJ. Nutritional guidelines and energy needs during pregnancy and lactation for active women. In: The active female: health issues throughout the lifespan. Springer; 2023. p. 363–78.
Prior JC, Hitchcock CL. The endocrinology of perimenopause: need for a paradigm shift. Front Biosci Scholar. 2011;S3:474–86.
Prior JC. Progesterone for the prevention and treatment of osteoporosis in women. Climacteric. 2018;21:366–74.
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Consensus statement: executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97:1159.
Prior JC. Innovations in women’s bone health—appreciating important “bone variables” besides estrogen. Int J Environ Res Public Health. 2018;15(9):1929.
Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379: e070750.
Tennfjord MK, Gabrielsen R, Tellum T. Effect of physical activity and exercise on endometriosis-associated symptoms: a systematic review. BMC Womens Health. 2021;21:1–10. https://doi.org/10.1186/s12905-021-01500-4.
Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102:604.
Velija-Ašimi Z. Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment. Bosn J Basic Med Sci. 2013;13:180.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110:364.
Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the united states: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab. 2022;107:575–85.
Bilir E, Yakın K, Ata B, Yıldız Ş. The impact of dysmenorrhea and premenstrual syndrome on academic performance of college students, and their willingness to seek help. Turk J Obstet Gynecol. 2020;17:196.
Tiranini L, Nappi RE. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Fac Rev. 2022. https://doi.org/10.12703/r/11-11.
Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest. 1964;16:244–8.
Maybin JA, Critchley HO. Medical management of heavy menstrual bleeding. Women’s Health. 2016;12:27.
Napolitano M, Dolce A, Celenza G, Grandone E, Perilli MG, Siragusa S, et al. Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses. Ann Hematol. 2014;93:557–63.
Acknowledgements
The author would like to acknowledge the support offered by Dr Stacy Sims (SPRINZ), Associate Professor Andrew Foskett (Massey University), Dr Sue Robinson and Glenn Kearney (High Performance Sport New Zealand) and Associate Professor Toby Mundel (Brock University) in their review of the resource and article. The feedback and insights throughout the development of the resource and their individual research in female health and performance are appreciated by the author.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author has no conflict of interest to report.
Funding
No external funding was provided for the development of resources or the article.
Author Contributions
CB wrote and revised the first draft of the manuscript and read and approved the final version.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Badenhorst, C. The Menstrual Health Manager (MHM): A Resource to Reduce Discrepancies Between Science and Practice in Sport and Exercise. Sports Med (2024). https://doi.org/10.1007/s40279-024-02061-w
Accepted:
Published:
DOI: https://doi.org/10.1007/s40279-024-02061-w